nodes	percent_of_prediction	percent_of_DWPC	metapath
Pamidronate—Xanthopsia—Furosemide—dilated cardiomyopathy	0.0509	0.0524	CcSEcCtD
Pamidronate—Breast cancer—Spironolactone—dilated cardiomyopathy	0.0468	0.0482	CcSEcCtD
Pamidronate—Tetany—Furosemide—dilated cardiomyopathy	0.0285	0.0294	CcSEcCtD
Pamidronate—Uremia—Lisinopril—dilated cardiomyopathy	0.0276	0.0284	CcSEcCtD
Pamidronate—Atrial flutter—Lisinopril—dilated cardiomyopathy	0.0183	0.0189	CcSEcCtD
Pamidronate—Histamine Phosphate—SLC22A5—dilated cardiomyopathy	0.018	1	CrCbGaD
Pamidronate—Local reaction—Furosemide—dilated cardiomyopathy	0.0168	0.0173	CcSEcCtD
Pamidronate—Hyperkalaemia—Spironolactone—dilated cardiomyopathy	0.0168	0.0173	CcSEcCtD
Pamidronate—Hypomagnesaemia—Furosemide—dilated cardiomyopathy	0.0146	0.0151	CcSEcCtD
Pamidronate—Renal failure acute—Spironolactone—dilated cardiomyopathy	0.0134	0.0138	CcSEcCtD
Pamidronate—Azotaemia—Lisinopril—dilated cardiomyopathy	0.0131	0.0135	CcSEcCtD
Pamidronate—Lethargy—Spironolactone—dilated cardiomyopathy	0.0127	0.013	CcSEcCtD
Pamidronate—Tubulointerstitial nephritis—Furosemide—dilated cardiomyopathy	0.0121	0.0125	CcSEcCtD
Pamidronate—Serum creatinine increased—Lisinopril—dilated cardiomyopathy	0.0113	0.0117	CcSEcCtD
Pamidronate—Fluid overload—Lisinopril—dilated cardiomyopathy	0.0112	0.0115	CcSEcCtD
Pamidronate—Cramp muscle—Spironolactone—dilated cardiomyopathy	0.0112	0.0115	CcSEcCtD
Pamidronate—Gastritis—Spironolactone—dilated cardiomyopathy	0.011	0.0113	CcSEcCtD
Pamidronate—Hypocalcaemia—Furosemide—dilated cardiomyopathy	0.0102	0.0105	CcSEcCtD
Pamidronate—Influenza-like symptoms—Lisinopril—dilated cardiomyopathy	0.00976	0.01	CcSEcCtD
Pamidronate—Renal failure—Spironolactone—dilated cardiomyopathy	0.00939	0.00967	CcSEcCtD
Pamidronate—Herpes zoster—Lisinopril—dilated cardiomyopathy	0.00926	0.00953	CcSEcCtD
Pamidronate—Pleural effusion—Lisinopril—dilated cardiomyopathy	0.00911	0.00937	CcSEcCtD
Pamidronate—Agranulocytosis—Spironolactone—dilated cardiomyopathy	0.00892	0.00918	CcSEcCtD
Pamidronate—Rhinorrhoea—Lisinopril—dilated cardiomyopathy	0.00861	0.00886	CcSEcCtD
Pamidronate—Thrombophlebitis—Furosemide—dilated cardiomyopathy	0.00779	0.00802	CcSEcCtD
Pamidronate—Arthropathy—Lisinopril—dilated cardiomyopathy	0.00767	0.00789	CcSEcCtD
Pamidronate—Swelling—Furosemide—dilated cardiomyopathy	0.00765	0.00787	CcSEcCtD
Pamidronate—Alopecia—Spironolactone—dilated cardiomyopathy	0.00758	0.0078	CcSEcCtD
Pamidronate—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.00718	0.00739	CcSEcCtD
Pamidronate—Musculoskeletal pain—Lisinopril—dilated cardiomyopathy	0.00706	0.00727	CcSEcCtD
Pamidronate—Anaphylactoid reaction—Furosemide—dilated cardiomyopathy	0.00697	0.00718	CcSEcCtD
Pamidronate—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00693	0.00713	CcSEcCtD
Pamidronate—Lethargy—Furosemide—dilated cardiomyopathy	0.00688	0.00709	CcSEcCtD
Pamidronate—Hyperkalaemia—Lisinopril—dilated cardiomyopathy	0.00685	0.00705	CcSEcCtD
Pamidronate—Influenza like illness—Lisinopril—dilated cardiomyopathy	0.00677	0.00697	CcSEcCtD
Pamidronate—Malaise—Spironolactone—dilated cardiomyopathy	0.00673	0.00693	CcSEcCtD
Pamidronate—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00668	0.00688	CcSEcCtD
Pamidronate—Blood urea increased—Lisinopril—dilated cardiomyopathy	0.00658	0.00678	CcSEcCtD
Pamidronate—Blood creatinine increased—Furosemide—dilated cardiomyopathy	0.00632	0.00651	CcSEcCtD
Pamidronate—Discomfort—Spironolactone—dilated cardiomyopathy	0.00628	0.00647	CcSEcCtD
Pamidronate—Pulmonary oedema—Lisinopril—dilated cardiomyopathy	0.00621	0.00639	CcSEcCtD
Pamidronate—Confusional state—Spironolactone—dilated cardiomyopathy	0.00614	0.00633	CcSEcCtD
Pamidronate—Hypokalaemia—Furosemide—dilated cardiomyopathy	0.00614	0.00632	CcSEcCtD
Pamidronate—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00609	0.00627	CcSEcCtD
Pamidronate—Cramp muscle—Furosemide—dilated cardiomyopathy	0.00607	0.00625	CcSEcCtD
Pamidronate—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00597	0.00614	CcSEcCtD
Pamidronate—Hepatic function abnormal—Lisinopril—dilated cardiomyopathy	0.00579	0.00596	CcSEcCtD
Pamidronate—Injury—Lisinopril—dilated cardiomyopathy	0.00551	0.00567	CcSEcCtD
Pamidronate—Renal failure acute—Lisinopril—dilated cardiomyopathy	0.00548	0.00564	CcSEcCtD
Pamidronate—Somnolence—Spironolactone—dilated cardiomyopathy	0.00542	0.00558	CcSEcCtD
Pamidronate—Atrial fibrillation—Lisinopril—dilated cardiomyopathy	0.00534	0.0055	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00526	0.00542	CcSEcCtD
Pamidronate—Anaphylactoid reaction—Lisinopril—dilated cardiomyopathy	0.00523	0.00538	CcSEcCtD
Pamidronate—Renal failure—Furosemide—dilated cardiomyopathy	0.00511	0.00526	CcSEcCtD
Pamidronate—Osteoarthritis—Lisinopril—dilated cardiomyopathy	0.00506	0.00521	CcSEcCtD
Pamidronate—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00502	0.00517	CcSEcCtD
Pamidronate—Agranulocytosis—Furosemide—dilated cardiomyopathy	0.00485	0.00499	CcSEcCtD
Pamidronate—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00482	0.00496	CcSEcCtD
Pamidronate—Blood creatinine increased—Lisinopril—dilated cardiomyopathy	0.00474	0.00488	CcSEcCtD
Pamidronate—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.00461	0.00474	CcSEcCtD
Pamidronate—Urethral disorder—Furosemide—dilated cardiomyopathy	0.00457	0.00471	CcSEcCtD
Pamidronate—Cramp muscle—Lisinopril—dilated cardiomyopathy	0.00456	0.00469	CcSEcCtD
Pamidronate—Nasopharyngitis—Lisinopril—dilated cardiomyopathy	0.00453	0.00466	CcSEcCtD
Pamidronate—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00449	0.00462	CcSEcCtD
Pamidronate—Gastritis—Lisinopril—dilated cardiomyopathy	0.00448	0.00461	CcSEcCtD
Pamidronate—Influenza—Lisinopril—dilated cardiomyopathy	0.00437	0.0045	CcSEcCtD
Pamidronate—Eye disorder—Furosemide—dilated cardiomyopathy	0.00436	0.00449	CcSEcCtD
Pamidronate—Pruritus—Spironolactone—dilated cardiomyopathy	0.00431	0.00444	CcSEcCtD
Pamidronate—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.0043	0.00443	CcSEcCtD
Pamidronate—Sweating increased—Lisinopril—dilated cardiomyopathy	0.00426	0.00439	CcSEcCtD
Pamidronate—Angiopathy—Furosemide—dilated cardiomyopathy	0.00423	0.00436	CcSEcCtD
Pamidronate—Immune system disorder—Furosemide—dilated cardiomyopathy	0.00422	0.00434	CcSEcCtD
Pamidronate—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00417	0.00429	CcSEcCtD
Pamidronate—Neutropenia—Lisinopril—dilated cardiomyopathy	0.00409	0.00421	CcSEcCtD
Pamidronate—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.00407	0.00419	CcSEcCtD
Pamidronate—Erythema—Furosemide—dilated cardiomyopathy	0.00406	0.00418	CcSEcCtD
Pamidronate—Malnutrition—Furosemide—dilated cardiomyopathy	0.00406	0.00418	CcSEcCtD
Pamidronate—Dizziness—Spironolactone—dilated cardiomyopathy	0.00403	0.00415	CcSEcCtD
Pamidronate—Dysgeusia—Furosemide—dilated cardiomyopathy	0.00398	0.0041	CcSEcCtD
Pamidronate—Pneumonia—Lisinopril—dilated cardiomyopathy	0.00392	0.00404	CcSEcCtD
Pamidronate—Muscle spasms—Furosemide—dilated cardiomyopathy	0.00391	0.00402	CcSEcCtD
Pamidronate—Vomiting—Spironolactone—dilated cardiomyopathy	0.00387	0.00399	CcSEcCtD
Pamidronate—Rash—Spironolactone—dilated cardiomyopathy	0.00384	0.00396	CcSEcCtD
Pamidronate—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00384	0.00395	CcSEcCtD
Pamidronate—Renal failure—Lisinopril—dilated cardiomyopathy	0.00383	0.00395	CcSEcCtD
Pamidronate—Headache—Spironolactone—dilated cardiomyopathy	0.00382	0.00393	CcSEcCtD
Pamidronate—Urinary tract infection—Lisinopril—dilated cardiomyopathy	0.00379	0.0039	CcSEcCtD
Pamidronate—Anaemia—Furosemide—dilated cardiomyopathy	0.00375	0.00387	CcSEcCtD
Pamidronate—Agitation—Furosemide—dilated cardiomyopathy	0.00373	0.00384	CcSEcCtD
Pamidronate—Haematuria—Lisinopril—dilated cardiomyopathy	0.00372	0.00383	CcSEcCtD
Pamidronate—Sinusitis—Lisinopril—dilated cardiomyopathy	0.00366	0.00377	CcSEcCtD
Pamidronate—Agranulocytosis—Lisinopril—dilated cardiomyopathy	0.00364	0.00375	CcSEcCtD
Pamidronate—Leukopenia—Furosemide—dilated cardiomyopathy	0.00364	0.00374	CcSEcCtD
Pamidronate—Nausea—Spironolactone—dilated cardiomyopathy	0.00362	0.00373	CcSEcCtD
Pamidronate—Rhinitis—Lisinopril—dilated cardiomyopathy	0.00351	0.00361	CcSEcCtD
Pamidronate—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.00346	0.00356	CcSEcCtD
Pamidronate—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.00343	0.00353	CcSEcCtD
Pamidronate—FDPS—cardiac ventricle—dilated cardiomyopathy	0.00335	0.317	CbGeAlD
Pamidronate—Confusional state—Furosemide—dilated cardiomyopathy	0.00334	0.00344	CcSEcCtD
Pamidronate—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.00332	0.00341	CcSEcCtD
Pamidronate—Shock—Furosemide—dilated cardiomyopathy	0.00326	0.00336	CcSEcCtD
Pamidronate—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.00325	0.00335	CcSEcCtD
Pamidronate—Flushing—Lisinopril—dilated cardiomyopathy	0.00325	0.00335	CcSEcCtD
Pamidronate—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.00325	0.00334	CcSEcCtD
Pamidronate—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00321	0.0033	CcSEcCtD
Pamidronate—Angiopathy—Lisinopril—dilated cardiomyopathy	0.00318	0.00327	CcSEcCtD
Pamidronate—Anorexia—Furosemide—dilated cardiomyopathy	0.00316	0.00325	CcSEcCtD
Pamidronate—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.00316	0.00325	CcSEcCtD
Pamidronate—FDPS—myocardium—dilated cardiomyopathy	0.00315	0.298	CbGeAlD
Pamidronate—Chills—Lisinopril—dilated cardiomyopathy	0.00314	0.00323	CcSEcCtD
Pamidronate—Hypotension—Furosemide—dilated cardiomyopathy	0.0031	0.00319	CcSEcCtD
Pamidronate—Alopecia—Lisinopril—dilated cardiomyopathy	0.00309	0.00319	CcSEcCtD
Pamidronate—Erythema—Lisinopril—dilated cardiomyopathy	0.00305	0.00314	CcSEcCtD
Pamidronate—Malnutrition—Lisinopril—dilated cardiomyopathy	0.00305	0.00314	CcSEcCtD
Pamidronate—Tension—Lisinopril—dilated cardiomyopathy	0.00299	0.00308	CcSEcCtD
Pamidronate—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.00299	0.00307	CcSEcCtD
Pamidronate—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00298	0.00306	CcSEcCtD
Pamidronate—Nervousness—Lisinopril—dilated cardiomyopathy	0.00296	0.00305	CcSEcCtD
Pamidronate—Back pain—Lisinopril—dilated cardiomyopathy	0.00295	0.00304	CcSEcCtD
Pamidronate—Somnolence—Furosemide—dilated cardiomyopathy	0.00295	0.00303	CcSEcCtD
Pamidronate—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.00293	0.00302	CcSEcCtD
Pamidronate—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00288	0.00297	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00286	0.00295	CcSEcCtD
Pamidronate—Fatigue—Furosemide—dilated cardiomyopathy	0.00286	0.00294	CcSEcCtD
Pamidronate—Pain—Furosemide—dilated cardiomyopathy	0.00284	0.00292	CcSEcCtD
Pamidronate—Constipation—Furosemide—dilated cardiomyopathy	0.00284	0.00292	CcSEcCtD
Pamidronate—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.00283	0.00291	CcSEcCtD
Pamidronate—Anaemia—Lisinopril—dilated cardiomyopathy	0.00282	0.0029	CcSEcCtD
Pamidronate—Angioedema—Lisinopril—dilated cardiomyopathy	0.00279	0.00287	CcSEcCtD
Pamidronate—Malaise—Lisinopril—dilated cardiomyopathy	0.00275	0.00283	CcSEcCtD
Pamidronate—Syncope—Lisinopril—dilated cardiomyopathy	0.00273	0.00281	CcSEcCtD
Pamidronate—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00273	0.00281	CcSEcCtD
Pamidronate—Leukopenia—Lisinopril—dilated cardiomyopathy	0.00273	0.00281	CcSEcCtD
Pamidronate—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00271	0.00279	CcSEcCtD
Pamidronate—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.00268	0.00276	CcSEcCtD
Pamidronate—Cough—Lisinopril—dilated cardiomyopathy	0.00266	0.00274	CcSEcCtD
Pamidronate—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00262	0.0027	CcSEcCtD
Pamidronate—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00262	0.0027	CcSEcCtD
Pamidronate—Myalgia—Lisinopril—dilated cardiomyopathy	0.0026	0.00267	CcSEcCtD
Pamidronate—Arthralgia—Lisinopril—dilated cardiomyopathy	0.0026	0.00267	CcSEcCtD
Pamidronate—Anxiety—Lisinopril—dilated cardiomyopathy	0.00259	0.00266	CcSEcCtD
Pamidronate—Discomfort—Lisinopril—dilated cardiomyopathy	0.00256	0.00264	CcSEcCtD
Pamidronate—Confusional state—Lisinopril—dilated cardiomyopathy	0.00251	0.00258	CcSEcCtD
Pamidronate—Oedema—Lisinopril—dilated cardiomyopathy	0.00249	0.00256	CcSEcCtD
Pamidronate—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.00249	0.00256	CcSEcCtD
Pamidronate—Infection—Lisinopril—dilated cardiomyopathy	0.00247	0.00254	CcSEcCtD
Pamidronate—Shock—Lisinopril—dilated cardiomyopathy	0.00245	0.00252	CcSEcCtD
Pamidronate—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00244	0.00251	CcSEcCtD
Pamidronate—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.00244	0.00251	CcSEcCtD
Pamidronate—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00243	0.0025	CcSEcCtD
Pamidronate—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.0024	0.00248	CcSEcCtD
Pamidronate—Asthenia—Furosemide—dilated cardiomyopathy	0.00238	0.00245	CcSEcCtD
Pamidronate—Anorexia—Lisinopril—dilated cardiomyopathy	0.00237	0.00244	CcSEcCtD
Pamidronate—Pruritus—Furosemide—dilated cardiomyopathy	0.00235	0.00241	CcSEcCtD
Pamidronate—Hypotension—Lisinopril—dilated cardiomyopathy	0.00232	0.00239	CcSEcCtD
Pamidronate—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00227	0.00234	CcSEcCtD
Pamidronate—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.00227	0.00233	CcSEcCtD
Pamidronate—Insomnia—Lisinopril—dilated cardiomyopathy	0.00225	0.00232	CcSEcCtD
Pamidronate—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00223	0.0023	CcSEcCtD
Pamidronate—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.00222	0.00228	CcSEcCtD
Pamidronate—Somnolence—Lisinopril—dilated cardiomyopathy	0.00221	0.00228	CcSEcCtD
Pamidronate—FDPS—heart—dilated cardiomyopathy	0.0022	0.208	CbGeAlD
Pamidronate—Dizziness—Furosemide—dilated cardiomyopathy	0.00219	0.00226	CcSEcCtD
Pamidronate—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00219	0.00225	CcSEcCtD
Pamidronate—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.00216	0.00223	CcSEcCtD
Pamidronate—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.00215	0.00221	CcSEcCtD
Pamidronate—Fatigue—Lisinopril—dilated cardiomyopathy	0.00214	0.00221	CcSEcCtD
Pamidronate—Constipation—Lisinopril—dilated cardiomyopathy	0.00213	0.00219	CcSEcCtD
Pamidronate—Pain—Lisinopril—dilated cardiomyopathy	0.00213	0.00219	CcSEcCtD
Pamidronate—Vomiting—Furosemide—dilated cardiomyopathy	0.00211	0.00217	CcSEcCtD
Pamidronate—Rash—Furosemide—dilated cardiomyopathy	0.00209	0.00215	CcSEcCtD
Pamidronate—Dermatitis—Furosemide—dilated cardiomyopathy	0.00209	0.00215	CcSEcCtD
Pamidronate—Headache—Furosemide—dilated cardiomyopathy	0.00208	0.00214	CcSEcCtD
Pamidronate—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00205	0.00211	CcSEcCtD
Pamidronate—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00203	0.00209	CcSEcCtD
Pamidronate—Nausea—Furosemide—dilated cardiomyopathy	0.00197	0.00203	CcSEcCtD
Pamidronate—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00197	0.00202	CcSEcCtD
Pamidronate—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00197	0.00202	CcSEcCtD
Pamidronate—FDPS—cardiac atrium—dilated cardiomyopathy	0.00188	0.178	CbGeAlD
Pamidronate—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00183	0.00189	CcSEcCtD
Pamidronate—Asthenia—Lisinopril—dilated cardiomyopathy	0.00178	0.00184	CcSEcCtD
Pamidronate—Pruritus—Lisinopril—dilated cardiomyopathy	0.00176	0.00181	CcSEcCtD
Pamidronate—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.0017	0.00175	CcSEcCtD
Pamidronate—Dizziness—Lisinopril—dilated cardiomyopathy	0.00165	0.00169	CcSEcCtD
Pamidronate—Vomiting—Lisinopril—dilated cardiomyopathy	0.00158	0.00163	CcSEcCtD
Pamidronate—Rash—Lisinopril—dilated cardiomyopathy	0.00157	0.00161	CcSEcCtD
Pamidronate—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00157	0.00161	CcSEcCtD
Pamidronate—Headache—Lisinopril—dilated cardiomyopathy	0.00156	0.0016	CcSEcCtD
Pamidronate—Nausea—Lisinopril—dilated cardiomyopathy	0.00148	0.00152	CcSEcCtD
